Encorafenib 75mg capsules
NHS hospitals in England used £44,994,252 of indicative cost of Encorafenib 75mg capsules in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 15.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Encorafenib 75mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Encorafenib 75mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Cambridge Univ Hosp Nhs Foundation Trust | £2,104,933 |
| Oxford University Hospitals Nhs Ft | £2,000,933 |
| Sheffield Teaching Hospitals Nhs Trust | £1,918,467 |
| Maidstone And Tunbridge Wells Nhs Trust | £1,696,800 |
| University Hospital Southampton Nhs Ft | £1,679,533 |
| The Christie Nhs Foundation Trust | £1,675,200 |
| Western Sussex Hospitals Nhs Found Trust | £1,598,333 |
| The Royal Marsden Nhs Foundation Trust | £1,589,041 |
| University Hpls Of Leicester Nhs Trust | £1,532,133 |
| Leeds Teaching Hpls Nhs Trust | £1,512,433 |
The primary-care picture
Encorafenib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Encorafenib medicine page.